Showing results (641-650 of 2,927) with videos related to
Sort By:
Pageof 293
Archives of Dermatology|January 17, 2007
Growth inhibition of Trichophyton species by Pseudomonas aeruginosaJames Treat, William D James, Irving Nachamkin, et al.The Journal of Parasitology|May 4, 2012
Hepatozoon infection prevalence in four snake genera: influence of diet, prey parasitemia levels, or parasite type?Beatriz Tomé, João P M C Maia, D James HarrisFolia Parasitologica|January 19, 2013
Molecular survey and microscopic examination of Hepatozoon Miller, 1908 (Apicomplexa: Adeleorina) in lacertid lizards from the western MediterraneanJoão P M C Maia, Ana Perera, D James HarrisThe Journal of Laryngology and Otology|December 14, 2006
Hearing threshold assessment post grommet insertion. Is it reliable?H Griffiths, D James, R Davis, et al.Chemistryopen|December 12, 2017
Fluorescence Sensing with Cellulose-Based MaterialsMeng Li, Xiaoning Li, Hui-Ning Xiao, et al.The British Journal of Surgery|January 1, 1989
Air-filled microballoon manometry for use in anorectal physiologyR Miller, D C Bartolo, D James, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 13, 2025
Presynaptic mu opioid receptors suppress the functional connectivity of ventral tegmental area dopaminergic neurons with aversion-related brain regionsYichen Wu, Tamara Perez-Rosello, Rajeshwar Awatramani, et al.Current Opinion in Neurobiology|October 22, 2023
Distributed dopaminergic signaling in the basal ganglia and its relationship to motor disability in Parkinson's diseaseShenyu Zhai, Qiaoling Cui, DeNard V Simmons, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2002
Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policyClaudia Thomas, Mark Stevenson, D James Williamson, et al.Journal of the American Geriatrics Society|December 11, 2002
Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trialJason H T Karlawish, David J Casarett, Bryan D JamesPageof 293